Recent data reveals that retatrutide, a innovative medication, could represent a significant step in body reduction . This drug combines the effects of a GLP-1 analog and a GIP receptor , possibly offering a greater impact than existing therapies . Clinical research have shown encouraging findings , including significant reductions in body and adva